The HANCOCK II ULTRA is sold by Medtronic Plc in the Tissue Sutured Mitral Valve Replacements market. Tissue sutured mitral valve replacements are used for replacement of the mitral heart valve using a biological prosthesis. One unit refers to one tissue sutured mitral valve replacement. Conventional suturing is used to keep these valves in desired place after surgery.

Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.

For a complete picture of Medtronic Plc’ Tissue Sutured Mitral Valve Replacements device pricing in China, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

This micro pricing report leverages GlobalData’s Global Brand Pricing tracker, which estimates brand-level selling prices (including discounts) of key medical devices in 30 countries. GlobalData’s Medical Intelligence Center uses a proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data. Medical device pricing data can be tracked by market, company, and brand globally.